1 study found for:    19118696 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)

Indicates status has not been verified in more than two years